Lactose (India) Ltd | 149 Cr. | 106 | 247/103 | 21.5 | 36.5 | 0.00 % | 18.0 % | 15.5 % | 10.0 |
MPS Pharmaa Ltd | 6.71 Cr. | 3.51 | 4.33/3.05 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 51.6 Cr. | 69.5 | 94.9/36.0 | 17.5 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 40.8 Cr. | 27.9 | 29.0/8.74 | 41.7 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 70.8 Cr. | 94.0 | 155/79.0 | 11.4 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 318 Cr. | 14.0 | 29.0/11.4 | 17.1 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 4.79 Cr. | 9.91 | 27.1/9.90 | 95.8 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 320 Cr. | 678 | 1,024/635 | 17.0 | 277 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 118 Cr. | 26.9 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 718 Cr. | 244 | 449/145 | 20.4 | 98.6 | 0.51 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 6.22 Cr. | 29.6 | 37.6/23.6 | 124 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 6.00 Cr. | 2.41 | 12.7/2.41 | | 17.2 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 252 Cr. | 260 | 307/110 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,108 Cr. | 1,174 | 1,584/970 | 56.7 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 141 Cr. | 1.52 | 2.72/1.03 | 30.0 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 30.2 Cr. | 12.6 | 16.6/6.40 | 36.4 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.8 Cr. | 11.7 | 24.6/11.0 | 51.5 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 270 Cr. | 758 | 999/355 | 9.95 | 570 | 0.26 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 35.5 Cr. | 35.5 | 45.0/26.1 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 27.4 Cr. | 60.1 | 84.4/36.0 | 56.0 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 9.97 Cr. | 3.99 | 26.5/2.97 | 39.9 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 15.4 Cr. | 103 | 154/52.2 | 38.6 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 9.00 Cr. | 16.4 | 19.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 47.2 Cr. | 62.6 | 124/55.4 | 29.9 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 5.17 Cr. | 17.2 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 14,619 Cr. | 843 | 871/344 | 62.3 | 53.3 | 0.12 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 92.1 Cr. | 21.3 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 12.5 Cr. | 24.7 | 46.0/21.2 | 157 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 160 Cr. | 277 | 418/245 | 16.4 | 110 | 1.62 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 21.6 Cr. | 36.6 | 62.6/12.8 | 61.6 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 64,146 Cr. | 1,095 | 1,593/986 | 18.0 | 527 | 0.41 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 141 Cr. | 226 | 307/137 | 40.4 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 769 Cr. | 154 | 265/150 | 15.3 | 60.5 | 1.63 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 39.4 Cr. | 30.2 | 63.2/29.8 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 8,934 Cr. | 2,183 | 2,644/1,008 | 73.5 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 5.88 Cr. | 0.89 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 282 Cr. | 36.7 | 77.7/35.1 | 19.8 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 8.16 Cr. | 14.0 | 27.3/11.9 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 76.6 Cr. | 3.25 | 6.25/2.82 | 116 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 62,894 Cr. | 29,597 | 31,900/25,200 | 47.1 | 1,657 | 1.39 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,697 Cr. | 739 | 837/430 | 26.9 | 205 | 0.41 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 104 Cr. | 36.5 | 75.8/35.7 | 18.1 | 47.8 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,162 Cr. | 784 | 1,078/440 | | 57.7 | 0.13 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 20,994 Cr. | 1,292 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 690 Cr. | 210 | 325/122 | 37.2 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 388 Cr. | 290 | 428/270 | 13.9 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,583 Cr. | 651 | 950/433 | 54.2 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,556 Cr. | 1,101 | 1,923/1,060 | 22.7 | 735 | 0.91 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,00,920 Cr. | 2,982 | 3,591/2,488 | 54.2 | 222 | 0.94 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,353 Cr. | 147 | 317/145 | 29.3 | 44.8 | 0.34 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,494 Cr. | 15.9 | 27.9/11.0 | 39.2 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 28,950 Cr. | 1,137 | 1,360/597 | 104 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,630 Cr. | 121 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,07,263 Cr. | 1,697 | 1,960/1,377 | 34.5 | 288 | 0.79 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,049 Cr. | 487 | 886/327 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,616 Cr. | 191 | 398/174 | 25.4 | 70.6 | 0.21 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 317 Cr. | 1,050 | 1,750/610 | 15.1 | 621 | 0.14 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,182 Cr. | 632 | 960/418 | 73.0 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,448 Cr. | 138 | 241/91.8 | 229 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 12,740 Cr. | 5,532 | 7,600/4,146 | 35.2 | 374 | 3.02 % | 49.2 % | 38.6 % | 10.0 |
RPG Life Sciences Ltd | 3,406 Cr. | 2,059 | 2,977/1,381 | 35.6 | 229 | 0.78 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,658 Cr. | 5,210 | 5,850/4,637 | 35.3 | 368 | 1.54 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 247 Cr. | 69.9 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 18,648 Cr. | 4,076 | 6,453/3,865 | 30.3 | 820 | 0.86 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 116 Cr. | 94.2 | 348/89.7 | 7.51 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 2,517 Cr. | 411 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 4,230 Cr. | 833 | 1,998/789 | 38.3 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 14,506 Cr. | 11,324 | 18,100/5,540 | 60.4 | 1,087 | 0.12 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 511 Cr. | 22.8 | 56.5/21.9 | 30.0 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 14,448 Cr. | 807 | 1,639/757 | 7.75 | 399 | 1.18 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 2,653 Cr. | 48.4 | 101/40.2 | 21.1 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 9,191 Cr. | 203 | 359/130 | 25.0 | 50.3 | 0.30 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 123 Cr. | 77.5 | 145/74.4 | 11.9 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 367 Cr. | 103 | 177/90.2 | 89.6 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 92,927 Cr. | 2,035 | 2,403/1,493 | 32.4 | 343 | 0.39 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,084 Cr. | 540 | 980/498 | 12.1 | 319 | 0.33 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 31,657 Cr. | 587 | 646/372 | 127 | 79.2 | 0.14 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 706 Cr. | 680 | 1,070/405 | 20.0 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 160 Cr. | 72.1 | 129/60.0 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 819 Cr. | 170 | 370/156 | 17.2 | 103 | 1.77 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 540 Cr. | 336 | 405/294 | 30.1 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 14,190 Cr. | 890 | 1,310/556 | 42.6 | 373 | 0.56 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 23,628 Cr. | 1,518 | 2,030/1,434 | 36.9 | 207 | 0.81 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,361 Cr. | 205 | 328/109 | 37.3 | 29.7 | 0.98 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 32,964 Cr. | 1,299 | 1,758/1,052 | 44.9 | 264 | 0.31 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,782 Cr. | 60.7 | 108/58.6 | 18.3 | 56.5 | 1.65 % | 12.3 % | 8.68 % | 2.00 |
Ind-Swift Ltd | 75.5 Cr. | 13.9 | 34.7/13.0 | 1.17 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 518 Cr. | 87.6 | 186/81.5 | 6.26 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,018 Cr. | 219 | 388/190 | | 118 | 0.69 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 4,733 Cr. | 384 | 465/262 | 63.5 | 97.6 | 0.31 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,150 Cr. | 1,352 | 3,379/1,253 | 37.2 | 355 | 0.44 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 3,278 Cr. | 327 | 504/278 | 40.0 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 11,413 Cr. | 471 | 725/382 | 23.8 | 141 | 0.32 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 39,652 Cr. | 1,405 | 1,831/908 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 45,025 Cr. | 2,658 | 3,088/1,825 | 52.7 | 98.7 | 1.20 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 25,617 Cr. | 1,555 | 2,221/1,411 | 22.8 | 557 | 1.29 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,364 Cr. | 391 | 659/364 | 23.2 | 141 | 1.28 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 17,085 Cr. | 1,255 | 1,594/816 | 51.9 | 204 | 0.59 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 92,452 Cr. | 1,108 | 1,421/1,092 | 17.2 | 369 | 0.72 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,291 Cr. | 210 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,18,065 Cr. | 1,462 | 1,702/1,317 | 23.7 | 351 | 0.89 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,001 Cr. | 1,842 | 2,641/1,221 | 27.2 | 334 | 0.27 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 267 Cr. | 102 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,204 Cr. | 114 | 186/92.2 | 14.2 | 95.8 | 0.44 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 70.2 Cr. | 43.2 | 92.0/42.0 | 117 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 38,785 Cr. | 323 | 405/244 | 47.1 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,641 Cr. | 1,706 | 2,326/1,100 | 40.0 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 131 Cr. | 82.2 | 158/76.3 | 18.0 | 43.2 | 1.46 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 191 Cr. | 80.7 | 113/67.8 | 40.9 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 19,189 Cr. | 7,676 | 8,140/4,050 | 114 | 272 | 0.31 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,703 Cr. | 589 | 863/548 | 34.5 | 103 | 0.78 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 224 Cr. | 107 | 145/69.9 | 8.92 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 56,038 Cr. | 4,687 | 6,440/4,407 | 25.9 | 961 | 0.84 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 16,263 Cr. | 827 | 1,304/725 | 27.4 | 249 | 1.33 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 461 Cr. | 808 | 1,754/804 | 11.4 | 724 | 1.42 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 31,706 Cr. | 2,538 | 3,486/2,050 | 35.3 | 294 | 1.42 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 2,987 Cr. | 267 | 571/258 | 21.0 | 120 | 1.91 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,128 Cr. | 340 | 635/332 | 23.7 | 126 | 0.29 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 17,068.14 Cr | 1,046.83 | | 41.00 | 182.72 | 0.37% | 16.01% | 16.31% | 6.24 |